YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer.
Ling-Chen LiXie-Wan ChenLing FangChun-Li JianYong-Xin YuXing-Yun LiaoJian-Guo SunPublished in: Canadian respiratory journal (2023)
. This trial is registered with NCT03513666.